Li-Zhu Lin (Lizhu Lin)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Small Cell Lung Cancer

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Journal of cellular and molecular medicine

Integrative cancer therapies

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Guo, Shan Liu, Huan Xia, Jiamin Luo, Hanrui Chen, Leihao Hu, Xinting Zheng, Zhiwei Xiao, Li-Zhu Lin
Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF-1α to ameliorate cancer-associated fatigue. Journal of cellular and molecular medicine 28 (12) (2024)
Wei Guo, Shan Liu, Huan Xia, Jiamin Luo, Hanrui Chen, Leihao Hu, Xinting Zheng, Zhiwei Xiao, Li-Zhu Lin
Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF-1α to ameliorate cancer-associated fatigue. Journal of cellular and molecular medicine 28 (12) (2024)
Wei Guo, Shan Liu, Huan Xia, Jiamin Luo, Hanrui Chen, Leihao Hu, Xinting Zheng, Zhiwei Xiao, Li-Zhu Lin
Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF-1α to ameliorate cancer-associated fatigue. Journal of cellular and molecular medicine 28 (12) (2024)
Wei Guo, Shan Liu, Huan Xia, Jiamin Luo, Hanrui Chen, Leihao Hu, Xinting Zheng, Zhiwei Xiao, Li-Zhu Lin
Shenqi Fuzheng injection facilitates skeletal muscle mitophagy mediated by the ubiquitination of HIF-1α to ameliorate cancer-associated fatigue. Journal of cellular and molecular medicine 28 (12) (2024)
Wenmin Chen, Jietao Lin, Ting Yang, Ze Xin Zhang, Lanting Tao, Zhiwei Xiao, Hanrui Chen, Xiangjun Qi, Lingling Sun, Yang Cao, Li-Zhu Lin
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study. Integrative cancer therapies 22 (2023)
Leihao Hu, Canfeng He, Aier Mo, Xingkai Zhan, Caizhi Yang, Wei Guo, Lingling Sun, Weiwei Su, Li-Zhu Lin
A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Wenmin Chen, Jietao Lin, Ting Yang, Ze Xin Zhang, Lanting Tao, Zhiwei Xiao, Hanrui Chen, Xiangjun Qi, Lingling Sun, Yang Cao, Li-Zhu Lin
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study. Integrative cancer therapies 22 (2023)
Jietao Lin, Lingling Sun, Hanrui Chen, Wenmin Chen, Zexin Zhang, Yang Cao, Li-Zhu Lin
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort). Integrative cancer therapies 22 (2023)
Leihao Hu, Canfeng He, Aier Mo, Xingkai Zhan, Caizhi Yang, Wei Guo, Lingling Sun, Weiwei Su, Li-Zhu Lin
A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Wenmin Chen, Jietao Lin, Ting Yang, Ze Xin Zhang, Lanting Tao, Zhiwei Xiao, Hanrui Chen, Xiangjun Qi, Lingling Sun, Yang Cao, Li-Zhu Lin
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study. Integrative cancer therapies 22 (2023)
Sheng-Xiong Zhang, Wen Tian, Yuan-Liang Liu, Jia-Hui Ni, Dan Zhang, Hua-Feng Pan, Zi-Ming Zhao, Bo Ai, Zhe-Sheng Chen, Li-Zhu Lin, Wei Liu
Mechanism of N-Methyl-N-Nitroso-Urea-Induced Gastric Precancerous Lesions in Mice. Journal of oncology 2022 (2022)
Zexin Zhang, Jing Li, Ke Lu, Wenfeng Wu, Ziyi Huang, Chi Zhang, Wei Guo, Jiayin Li, Li-Zhu Lin
Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer. Journal of oncology 2022 (2022)
Hongwei Zhao, Lingling Sun, Xi Xiao, Jietao Lin, Lizhu Lin, Li-Zhu Lin
Qu-Yu-Jie-Du Decoction Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulation of Neutrophils and Macrophage Infiltration. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Hongwei Zhao, Lingling Sun, Xi Xiao, Jietao Lin, Lizhu Lin, Li-Zhu Lin
Qu-Yu-Jie-Du Decoction Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulation of Neutrophils and Macrophage Infiltration. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Xiangjun Qi, Zehuai Guo, Qianying Chen, Wanning Lan, Zhuangzhong Chen, Wenmin Chen, Li-Zhu Lin
A Data Mining-Based Analysis of Core Herbs on Different Patterns (Zheng) of Non-Small Cell Lung Cancer. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Xiangjun Qi, Hongbin Xu, Peng Zhang, Guoming Chen, Zhiqiang Chen, Caishan Fang, Li-Zhu Lin
Investigating the Mechanism of Scutellariae barbata Herba in the Treatment of Colorectal Cancer by Network Pharmacology and Molecular Docking. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)